DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Roche H, Fumoleau P, Spielmann M. et al.
Five years analysis of the PACS 01 trial: 6 cycles of FEC100 vs 3 cycles of FEC 100 followed by 3 cycles of docetaxel (D) for the adjuvant treatment of node positive breast cancer.
Breast cancer Res Treat 2004; 88 (suppl 1) , abstr 27
We do not assume any responsibility for the contents of the web pages of other providers.